Jason N. Gorevic, Chief Executive Officer at Teladoc Health, Inc. (TDOC), sold 14,900 shares at $154.12 ($2.3M) on 2021-05-04, disclosed to the SEC on 2021-05-06.
Seasonal sale ($2.3M) by Chief Executive Officer — this insider has traded TDOC in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.12 | 1,300 | $200K | 8.6% |
| 2 | $155.06 | 1,000 | $155K | 6.6% |
| 3 | $156.24 | 2,400 | $375K | 16.1% |
| 4 | $156.95 | 3,853 | $605K | 25.9% |
| 5 | $156.95 | 3,853 | $605K | 25.9% |
| 6 | $158.30 | 1,047 |
| $166K |
| 7.1% |
| 7 | $158.30 | 1,047 | $166K | 7.1% |
| 8 | $159.52 | 300 | $48K | 2.0% |
| 9 | $160.50 | 100 | $16K | 0.7% |
| Total | $156.73 avg | 14,900 | $2.3M | 100% |
| Filing → |
| TDOC | SELL | 2024-03-05 | $1.6M | — | Filing → |
| TDOC | SELL | 2023-12-05 | $109K | — | Filing → |
| TDOC | SELL | 2023-09-06 | $131K | — | Filing → |